Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Pharmaceutical Care ...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Pharmaceutical Care España
Article . 2022 . Peer-reviewed
License: CC BY NC SA
Data sources: Crossref
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Pharmaceutical Care España
Article . 2022
Data sources: DOAJ
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Pharmaceutical Care España
Article . 2022
Data sources: DOAJ
versions View all 3 versions
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Enfermedades raras desde la farmacia comunitaria

Authors: Eloisa Maria De Velasco; Purificación Ballester Navarro; Cerdá Begoña; Miguel Ángel Ruiz-Carabias; Pilar Zafrilla;

Enfermedades raras desde la farmacia comunitaria

Abstract

Introducción: la visibilidad de las Enfermedades Raras a nivel multidisciplinar y su humanización, son uno de los retos planteados en la Agenda 2030 de Naciones Unidas. El farmacéutico comunitario necesita renovarse y promover habilidades, como técnicas de atención farmacéutica individualizada, imprescindibles para el apoyo de estos pacientes. El objetivo de esta investigación es identificar las necesidades socio-sanitarias de las familias pertenecientes a asociaciones de enfermedades raras que acude a la farmacia comunitaria en España. Método: Estudio observacional y transversal mediante cuestionario digital enviado a usuarios de la Asociación de Enfermedades Raras D´genes, a través de la Asociación y de los Colegios Oficiales de Farmacéuticos, n=253. Resultados: las enfermedades raras se distribuyen por todo el territorio con una alta dispersión. La mayoría de pacientes o familiares suelen visitar la farmacia comunitaria más de dos veces al mes. Estas familias suelen confiar en su farmacia desde hace más de tres años y no encuentran dificultades para obtener su tratamiento. El perfil de los pacientes que acuden a la farmacia es muy heterogéneo, pero la mayoría de familiares afirman conocer y centrarse únicamente en sus necesidades sociosanitarias. En relación a sus niveles de satisfacción, el recibimiento, la discreción en el trato, el tiempo de atención y la despedida son los factores mejor valorados. Conclusiones: El profesional farmacéutico debe poseer, habilidades científicas y técnicas, necesita promover valores como empatía, habilidades sociales o capacidad de escucha, para poder prestar una atención farmacéutica personalizada a familias con enfermedades raras y conseguir humanizar la farmacia comunitaria del siglo XXI. 

Keywords

RS1-441, Pharmacy and materia medica, Enfermedades raras; Atención al paciente; Farmacia comunitaria; Profesional farmacéutico; Humanización

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
gold